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Abstract: A series of new hybrid type squaramide-fused amino alcohol (SFAA) catalysts were 
synthesized and their catalytic efficiency in enantioselective nitro-aldol reaction of various isatins 
with nitromethane that afford the chiral 3-substituted 3-hydroxyoxindoles in excellent chemical 
yields (up to 99%) and high enantioselectivities (up to 95% ee) is described. The resulting chiral 
3-hydroxyoxindoles could be used as synthetic precursors for the synthesis of several natural 
products with a broad spectrum of fascinating biological activities. 
 
Introduction:  
Although the concept of utilizing organic molecules as catalysts started long ago,[1] 
enantioselective organocatalysis has emerged as one of the most intensively investigated areas in 
organic chemistry since last two decades.[2] Small organic molecules as catalysts could provide 
complex organic transformations with high levels of stereoselectivity in environmentally and 
economically friendly manner. Owing to their significance, the development of new 
organocatalysts and evaluation of their catalytic efficiency in organic transformations is still a 
challenging task. In recent years, we have been exploring the role of simple primary amino 
alcohols as new class of organocatalysts with distinctive properties such as easy synthesis, stability 
on exposure to air, potential for convenient alteration of the steric sites and ability to be used as 
bi-functional (enamine activation and non-covalent activation) catalysts.[3] Organocatalysis using 
chiral hydrogen-bond (H-bond) donor catalysts, such as thioureas and squaramides,[4] has 
expanded rapidly in the past few years. This type of catalysis now efficiently addresses the issue 
of the formation of multiple chiral centers with high stereoselectivitys. Nitro-aldol reaction (Henry 
reaction)[5] is one of the prominent coupling reactions between a carbonyl compound and a nitro 
alkyl compound bearing α- hydrogens, leading to the formation of a new C-C bond with the 
concomitant generation of β-nitro alcohol, a new bi-functional moiety, which could further provide 
efficient routes to highly valuable and functionalized derivatives such as 1,2-amino alcohols or 
amino acids.[6] Importantly, asymmetric aldol reaction of cyclic ketones generates a quaternary 
stereocenter, which is a challenging task in asymmetric synthesis. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Utility of Chiral 3-Alkyl-3-Hydroxyindoles 
Specifically, asymmetric nitro-aldol reaction of isatins with    nitroalkanes could provide chiral 3-
substituted 3-hydroxyoxindole core units[7]  with nitro functional group, which are important 
synthetic precursors for many biologically active natural products such as CPC-1 (antibacterial 
activity),[8a] maremycine B (cytotoxicity against K562 human leukemia cell lines),[8b] 
spirobrassinin (antifungal, antitumor and oviposition stimulation activity),[8c] donaxaridine 
(anticancer activity),[8d,e] and dioxobrassinin (Scheme 1). Furthermore, these 3-hydroxyindoles 
could also be used as intermediates for newly designed drugs. Although there have been a few 
reports[9] on the asymmetric nitro aldol reaction of isatins with nitroalkanes, all of them utilize the 
cinchona alkaloid derivatives as organocatalysts for this transformation. In continuation of our 
efforts towards expanding the scope of amino alcohols and their derivatives as organocatalysts,[3] 
we herein focused on the synthesis of squaramide-fused amino alcohols A and B, which have 
multiple hydrogen bonding sites and stereoinduction sites in the same molecule, and evaluated 
their catalytic activity for the nitro-aldol reaction of isatins with nitroalkanes. These simple amino 
alcohols with covalent and noncovalent hydrogen bonding sites in the same molecule work as 
efficient organocatalysts for many enantioselective reactions.[3] In recent years, squaramide based 
catalysts containing two amino hydrogen bonding sites in four membered ring system have been 
explored rigorously.[10] Being nitrogenated derivatives of squaric acid, squaramides are considered 
as vinylogous amides (Scheme 2, structure II), whereas, the corresponding urea and thiourea 
derivatives are normal (thio) amides (Scheme 2, structure I). Hence, the rotation of C-N single 
bond is restricted due to the delocalization of lone pair of electrons on nitrogen atom through the 
carbon-oxygen double bond of cyclobutenedione system and also further delocalization can occur 
due to the partially aromatic character of cyclobutanedione system.[11a] Moreover, Takemoto[11b] 
and Rawal[11c] groups have calculated the distances between the two N-H groups for N,N’-
dimethylthiourea III and N,N’-dimethylsquaramide IV to be approximately 2.13 Å and 2.72 Å, 
respectively. And also, the square geometric structure of the cyclobutenedione ring also induces a 
convergent orientation of the N-H groups, canting each by approximately 6o (Scheme 2, structure 
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VI). [11c] Because of all these peculiar properties, squaramide moieties could have greater linearity 
to make stronger hydrogen bonds with the substrates. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. Comparison of zwitterionic forms of the urea/thiourea and squaramide skeletons (I & II), H-bond spacing 
distances (III & IV), disposition of hydrogen bonds in N,N’-dimethylthiourea and N,N’-dimethylsquaramide (V &VI). 
 
Previously reported catalyst A containing two amino and one hydroxyl group as hydrogen bonding 
sites show efficient catalytic activity in the enantioselective allylation reaction.[12] On the other 
hand, our newly designed catalyst B contains a cyclic tertiary amino group, which can act as 
Brønsted base as well as steric influence site along with two amino and one hydroxyl group which 
could make hydrogen bonding with both isatins and nitroalkanes (Scheme 3). Catalyst B could be 
easily prepared by the condensation of squarate methyl ester amide with the corresponding amino 
alcohols and due to the presence of multiple hydrogen bonding sites and steric factors in one 
molecule, it could show strong influence in controlling the stereoselectivity for the reaction of 
isatins with nitromethane as shown in the plausible transition state X (Scheme 3). Thus, isatins and 
nitromethane could be conformationally fixed by four hydrogen bonding interactions between the 
two amino groups on the squaramide site and two carbonyl groups on isatins, between the cyclic 
ammonium site and the oxygen atom on the nitro enolate moiety, and between the cyclic 
ammonium site and the hydrogen on the hydroxyl group in the ammonium alcohol intermadiate. 
And then, the reaction might proceed stereoselectively to afford the nitro-aldol product with high 
enantioselectivity.  
Herein, we describe the synthesis of new type squaramide fused amino alcohol organocatalysts 
and their catalytic efficiency for the enantioselective nitro-aldol reaction of isatins with 
nitromethane as the first example using this class of organocatalysts to afford the corresponding 
aldol products with excellent chemical yields and enantioselectivities (up to 98%, up to 95% ee). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Concept of catalyst design 
Results and Discussion 
The previous reported simple squaramide fused amino alcohol catalyst 4c[9] and other new 
derivatives 4a,b,d were synthesized by the coupling of squarate monoester amide 3 with the 
corresponding β-amino alcohols 2a-d, which were obtained easily from commercial available 
amino esters 1a-d via Grignard reaction (Scheme 4).[3d-f] 
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Scheme 4. Synthesis of Usual Type of SFAA Catalysts 4a-d 
 
With the catalysts 4a-d in hand, we desire to examine the catalytic activity of these catalysts in 
nitro-aldol reaction (Table 1). Initially, we carried out the reaction of simple isatin 5a with 
nitromethane 6 using catalyst 4a in THF at 0 oC in the absence of any basic additive. However, the 
expected aldol product 7a was not observed even after 48 h and the starting compound 5a could 
be recovered completely (entry 1). Then we hypothesized that addition of a basic additive might 
initiate the reaction. To implement this hypothesis, the basic additives such as TEA, DIPEA and 
DMAP were used in the course of reaction to abstract the proton from nitromethane (entries 2-4). 
By using these basic additives, the reaction was proceeded smoothly and the expected aldol 
product 7a was obtained, but the better results observed by using DMAP as additive (entry 4, 83%, 
38% ee). Then, different SFAA catalysts 4b-d, were tested and each catalyst showed considerable 
catalytic activity and furnished the product 7a in good yields (up to 83%), although the ee values 
were not satisfactory (entry 5-7, upto 32% ee). Among the tested catalysts, 4a was found to be the 
best one to furnish the aldol product 7a in good chemical yield, though the enantioselectivity was 
not satisfactory. Different substituted isatins 5b, and 5c were examined using catalyst 4a under the 
same reaction conditions. The reactions of N-methylated isatin 5b and N-benzylated isatin 5c, 
afforded the respective aldol products 7b and 7c in moderate chemical yields and poor 
enantioselectivities (entries 8-9). A quick solvent screening was performed. The reaction 
proceeded efficiently in DCM and CHCl3 furnished the aldol products 7a in good yield, albeit in 
racemic form (entries 10-11). These results revealed that catalysts 4a-d were inefficient to yield 
the aldol products with satisfactory enantioinduction and that a basic additive is necessary for the 
reaction to proceed. With these results in hand, we assumed that the introduction of tertiary amino 
group into the core structure of SFAA catalyst could improve the catalytic activity and 
enantioselectivity of the reaction. 
 
Table 1. Nitro-Aldol Reaction of Isatins with Nitromethane Using Catalysts 4a-d 
 
 
entrya 
catalyst 
4 
5 R base solvent 7 
yield 
(%)b 
ee 
(%)c 
1d a a H -- THF -- --- --- 
2 a a H TEA THF a 12 8 
3 a a H DIPEA THF a 25 11 
4 a a H DMAP THF a 83 38 
5 b a H DMAP THF a 82 32 
6 c a H DMAP THF a 83 31 
7 d a H DMAP THF a 82 32 
8 a b Me DMAP THF b 62 23 
9 a c Bn DMAP THF c 75 11 
10 a a H DMAP DCM a 92 rac 
11 a a H DMAP CHCl3 a 85 rac 
aThe reactions were carried out with 5 (0.13 mmol), 6 (0.67 mmol) in mentioned dry solvents (2.0 mL). bIsolated yields. cEnantiomeric excess was 
determined by chiral HPLC on chiralpak-AD-H column.d without base. 
To test our hypothesis, we synthesized the new hybrid type SFAA catalysts 14a-e in few steps 
from commercially available L-serine methyl ester (Scheme 5). Grignard reaction of ammonium 
ester 8 using PhMgBr furnished the β-amino alcohol 9 in moderate yield. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Scheme 5. Synthesis of New SFAA Catalysts 14a-e. 
The free amino function of 9 was protected with Boc group by treatment with (Boc)2O in the 
presence of Et3N to afford 10, followed by the protection of primary hydroxyl group to result in 
the O-mesylated derivative 11 in good yield. Subsequently, mesyl function of 11 was replaced 
with various cyclic amines (pyrrolidine, piperidine, azepane, morpholine and thiomorpholine) 
under the neat reaction conditions to provide the compounds 12a-e in moderate to good yields. 
De-protection of Boc group of 12a-e by treating with TFA furnished 13a-e, and a further coupling 
with squarate monoester amide 3 afforded the targeted new type organocatalysts 14a-e in good 
overall yields (Scheme 5).  
Next, we examined the catalytic activity of synthesized catalysts 14a-e using the best solvent 
i.e. THF (Table 2). As the first attempt, catalyst 14a bearing pyrrolidine ring system as a basic site 
was tested for the nitro-aldol reaction of simple isatin 5a with nitromethane 6 at 0°C. Surprisingly, 
respective aldol product 7a was obtained in excellent chemical yield (99%) with better 
enantioselectivity (64% ee) (entry 1). Inspired by these results, we decided to examine the catalytic 
activity of other synthesized SFAA catalysts in this reaction. Catalyst 14b bearing piperidine ring 
system as a basic site afforded 7a with excellent chemical yield but with low enantioselectivity 
(39%) (entry 2). The best enantioselectivity (81% ee) with good chemical yield (92%) was 
obtained by using catalyst 14c bearing azepane ring system (entry 3). On the other hand, other two 
catalysts 14d bearing morpholine and 14e bearing thiomorpholine ring systems, afforded the aldol 
product 7a in only trace amounts (entries 4-5). Fortunately, performing these reactions at room 
temperature successfully afforded the desired aldol product 7a in good chemical yields with 
moderate enantioselectivities (14d: 85%, 61% ee; 14e: 98%, 59% ee) (entries 6-7), but these results 
were not better than those obtained with 14c. 
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Table 2. Nitro-Aldol Reaction Using Catalysts 14a-e 
 
 
entrya catalyst 14 temp. (oC) yield (%)b ee (%)c 
1 a 0 99 64 
2 b 0 92 39 
3 c 0 92 81 
4 d 0 trace -- 
5 e 0 trace -- 
6 d RT 85 61 
7 e RT 98 59 
a The reactions were carried out with 5a (0.13 mmol), 6 (0.67 mmol) in 
dry THF (2.0 mL). bIsolated yields. cEnantiomeric excess was determined by chiral HPLC on chiralpak AD-H column 
We next inspected the effect of solvent, the molar ratio of catalyst, and reaction temperature 
(Table 3, entries 1-20). Changing the molar ratio of catalyst 14c to 5 mol% and 20 mol% also 
provided the aldol product 7a in good chemical yields and enantioselectivity (5 mol%: 82%, 74 % 
ee, 20 mol%: 93%, 64% ee), respectively (entries 1-2). At lower reaction temperature i.e -20 oC, 
both the chemical yield and enantioselectivity dropped to 70% and 78% ee respectively (entry 3). 
The use of non-polar aromatic solvents also gave 7a with excellent chemical yields (89-95%), but 
completely in racemic form (entries 4-6). Furthermore, the reaction in chlorinated solvents and 
different ethereal solvents afforded 7a in good to excellent chemical yields (86-94%) (except THP, 
in which case only trace amount of 7a was formed), but very poor to moderate enantioselectivities 
were observed (entries 7-12). Furthermore, the effect of polar solvents such as TFE, ACN, DMA, 
DMF, DMSO and MeOH were also investigated. Unfortunately, satisfactory chemical yields and 
enantioselectivities were not obtained (entries 13-18). The reaction was also conducted in water 
and in neat conditions (nitromethane used as solvent and reactant). Although, the product 7a was 
obtained in fairly good chemical yields, good enantioinduction was not observed (entries 19 and 
20). 
Table 3. Optimization of Nitro-Aldol Reaction Using Catalyst 14c 
 
entrya 
catalyst 
(mol%) 
solvent temp. (oC) 
yield 
(%)b 
ee (%)c 
1 5 THF 0 82 74 
2 20 THF 0 93 64 
3 10 THF -20 70 78 
4 10 Toluene 0 89 rac 
5 10 Benzene 0 98 rac 
6 10 m-Xylene 0 95 rac 
7 10 DCM 0 86 2 
8 10 Diisopropylether 0 93 2 
9 10 CPME 0 86 rac 
10 10 1,4-Dioxane 0 94 55 
11 10 Et2O 0 93 21 
12 10 THP 0 trace -- 
13 10 TFE 0 94 rac 
14 10 ACN 0 91 53 
15 10 DMA 0 43 74 
16 10 DMF 0 57 64 
17 10 DMSO RT trace -- 
18 10 MeOH 0 92 rac 
19 10 Water RT 92 rac 
20 10 Neat 0 96 rac 
aThe reactions were carried out with 5a (0.13 mmol), 6 (0.67 mmol) in mentioned dry solvents (2.0 mL).bIsolated yields. cEnantiomeric excess was 
determined by chiral HPLC on chiralpak AD-H column 
After rigorous screening of catalysts, catalyst loadings, additives, solvents and reaction 
temperatures, we decided to set the conditions in entry 3 of Table 2 as our optimal conditions for 
this reaction and started to explore the substrate scope. The generality of this protocol was fully 
demonstrated by evaluating a variety of isatins and nitromethane and the respective nitro-aldol 
products 7b-k were accomplished in good to excellent yields and poor to good enantioselectivities 
(Scheme 6). The reactions of N-alkylated isatins i.e N-methyl-isatin 5b, N-benzyl-isatin 5c and N-
allyl-isatin 5d with afforded the desired aldol products 7b-d, respectively, in excellent chemical 
yields (95-98%) but with low to moderate enantioselectivity (26-67% ee). On the other hand, the 
reaction of N-Boc isatin 5e proceeded smoothly and accomplished the respective product 7e in 
good chemical yield (82%) with excellent enantioselectivity (95% ee). 5-Methyl-isatin 5f provided 
the aldol product 7f in excellent chemical yield (96%) with low selectivity (35% ee). Moreover, 
only trace amount of the aldol product 7g was obtained from the reaction of 5-NO2-isatin 5g with 
6, although the exact reason was not clear. The use of halogenated isatins 5h-k provided the 
corresponding nitro aldol products 7h-k with fairly good to excellent chemical yields (89-97%), 
but with moderate enantioselectivity (52-64% ee). We also tried this protocol for superior 
nitroalkanes (Nitroethane, Nitropropane), but unfortunately does not yield the corresponding 
products with stereoselectivity (corresponding products were obtained in complete racemic form), 
although the reason was not clear. 
Scheme 6.  Substrate Scope of Nitro-Aldol Reaction 
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         Finally, the enantioselective reaction mechanistic pathway of this reaction using 
our squaramide-fused amino alcohol catalyst 14c was considered based on both the high 
enantiopurity (81% ee) of the chiral aldol product (S)-7a which was obtained from the reaction of 
isatin 5a with nitromethane 6 and the calculation analysis (a: natural bonding orbital (NBO)[13] 
analysis of the hydrogen bonding of simple squaramide VII with isatin 5a or nitrometane 6, b:  the 
hydrogen bonding distance calculations of complexes A or B, c: electron density of isatin 5a) 
(Figure 1). Thus, (a) NBO analysis was performed subsequently on the optimized structures to 
quantify the donor-acceptor. The stabilization energies (E (2)) of intermolecular interactions of all 
complexes (complexes A and B) were performed by using second order perturbation theory.  As 
the calculation result, the stability of A (E(2) / kcal·mol-1 = 1.56) was increased as compared with 
that of B (E(2) / kcal·mol-1 = 0.25). This result might be consistent with the stability of the 
complexes. Furthermore, (b) the hydrogen bonding distance of complex A was also shorter than 
that of complex B. In addition, (c) the place of the highest electron density (Mulliken charge 
distribution) was on oxygen of amide in isatin 5a.  
 
       From these knowledge, a model for the enantioselective reaction mechanistic pathway is 
proposed as follows (Scheme 7). First, the active methylene proton of nitromethane is abstracted 
by basic tertiary amino group on azepane ring in catalyst 14c to form nitro enolate, which might 
also induce the strong hydrogen bonding interaction between the hydrogen atom of the ammonium 
moiety on azepane ring in catalyst and oxygen atom of nitro enolate. Next, isatin 5a might fixed 
with catalyst 14c through two hydrogen bonds between two carbonyl oxygen atom on isatin 5a 
and two primary amino groups on squaramide site in catalyst. When isatin 5 makes the hydrogen 
bonding to catalyst, one carbonyl oxygen atom of amide on isatin 5a might binds with the hydrogen 
atom of amino group with 3,5-Bis(trifluoromethyl)phenyl group as an electron-withdrawing group 
on squaramide site in catalyst and other carbonyl oxygen atom on isatins 5a might binds with the 
hydrogen atom of another amino group on squaramide in catalyst. In addition, the side chain 
containing ammonium alcohol moiety on catalyst might be fixed by the hydrogen bonding 
interaction between hydrogen atom on the hydroxyl group and ammonium moiety on azepane ring 
on the side chain. Among the possible two transition states TS-I and TS-II, TS-II has less steric 
interaction than that of TS-I, which has strong steric repulsion between four membered squaramide 
skeleton and di-phenyl groups on catalyst. Hence the reaction might proceed via the transition state 
TS-II, in which nitroenolate coordinated to ammonium moiety on azepane ring could attack the 
isatin from the upper side (Si face) leading to the formation of (S)-7a as major enantiomer, whereas 
minor isomer (R)-7a might be obtained via the unfavorable transition state TS-I. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. (a) The calculated second order perturbation energies (E (2) / kcal, Eamol-1) of the second donor (H-bond 
donor of squaramides) and acceptor (Oxygenatoms of Isatins 5a and nitrate 6) interaction for the complexes A and 
B, (b) the calculated hydrozen bond distances of the complexes A and B, (c) The electron density map and Mulliken 
charge distribution of isatins 5a. 
Scheme 7. Plausible reaction course.  
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Conclusions 
In summary, we have synthesized squaramide-fused amino alcohol (SFAA) catalysts 4a-d and 
newly designed SFAA catalysts 14a-e from commercial available amino esters via simple organic 
transformations and demonstrated their catalytic efficiency in the asymmetric nitro aldol reaction 
of various isatins and nitromethane. This protocol provides the chiral 3-substituted 3-
hydroxyoxindoles in excellent chemical yields (up to 99%) and high enantioselectivities (up to 
95% ee). Catalyst 14c bearing azepane ring system as basic site showed best catalytic activity for 
this reaction among all synthesized catalysts. The resulted 3-alkylsubstituted 3-hydroxyoxindoles 
could be crucial intermediates for the synthesis of many significant biologically active scaffolds. 
The feasible mechanistic path of this reaction using our newly synthesized catalyst 14c was also 
explained by calculated the second order perturbation energies of second donor [H-bond donor of 
squaramide] and acceptor [oxygen atoms of isatin 5a and nitromethane 6] and hydrogen bond 
distances between catalyst 14c and isatin 5a, and nitromethane 6. 
Experimental Section  
General Methods. All commercial reagents were purchased and used without further purification. 
All reactions were carried out under an argon atmosphere in flame-dried glassware with magnetic 
stirring. Thin layer chromatography (TLC) was performed on silica gel 60 F254 and analytes were 
detected using UV light (254 nm) and iodine vapor. Column chromatography was carried out on 
silica gel 60N (40–100 µm) and preparative TLC was carried out on silica gel 60 F254. Melting 
points were measured using a micro-melting point apparatus. Infrared (IR) spectra were measured 
with a FT/IR spectrophotometer. 1H-NMR (500 MHz) and 13C-NMR (125 MHz) spectra were 
measured in CDCl3, (CD3)2SO. 
1H-NMR spectra data were reported as follows: chemical shifts in 
ppm from tetramethylsilane (0.0 ppm) or the residual solvent as an internal standard ((CD3)2SO; 
2.50 ppm), integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet-
doublet, m = multiplet and br = broad), coupling constants (Hz), and assignment. 13C-NMR spectra 
were measured with complete proton decoupling. Chemical shifts were reported in ppm from the 
residual solvent as an internal standard (CDCl3: 77.16 ppm). High performance liquid 
chromatography (HPLC) was performed using the chiral columns AD-H, AS-H 4.6 mm x 25 cm 
columns. Optical rotations were measured with a digital polarimeter. HRMS spectra were 
performed by EI and FAB using sector instruments. 
General procedure for synthesis of catalysts 4a-d. To a stirred solution of squarate mono amide 
ester 3 (149 mg, 1 mmol) in dry MeOH (5 mL) was added corresponding β-aminoalcohol 2a-d (1 
mmol) at room temperature and allowed the reaction mixture to stirred for 12 h at same temperature. 
After completion of reaction indicated by TLC, the excess MeOH was evaporated under reduced 
pressure results the crude reaction mixture, which was purified by flash column chromatography 
using Hexane:EtOAC (6:4) as eluent to afforded the targeted organocatalysts 4a-d as pure 
compounds in moderate to good yields. 
 
(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((1-hydroxy-1,1-diphenylpropan-2-
yl)amino)cyclobut-3-ene-1,2-dione (4a). Pale yellow solid (MeOH). 170 mg, 70% yield. m.p. 
202-205 °C. [α]D24 = -38 (c = 0.5, MeOH ). IR (neat) = 3223, 2980, 1687, 1417, 1115, 825 cm-1. 
1H NMR (500 MHz, DMSO-d6): δ 10.40 (s, 1H), 8.03 (s, 2H), 7.99 (d, J = 10.50 Hz, 1H), 7.62 (s, 
1H), 7.51 (t, J = 7.00 Hz, 3H), 7.40 (t, J = 7.50 Hz, 2H), 7.26-7.20 (m, 3H), 7.09 (t, J = 7.50 Hz, 
1H), 6.42 (s, 1H), 1.00 (d, J = 7.0 Hz, 3H), 0.83 (d, J = 7.00 Hz, 3H).  13C NMR (125 MHz, DMSO-
d6): δ 184.6, 180.0, 170.1, 161.8, 146.2, 145.3, 141.1, 128.3, 127.8, 126.8, 126.4, 125.7, 125.6, 
124.2, 122.1, 117.9, 114.6, 81.1, 63.6, 28.7, 22.3, 17.5. EI-MS m/z: 534 (M)+, 556.8 (M + Na)+. 
HRMS (EI) calcd for C27H20F6N2O3 m/z: 534.1378 (M)
+ found: 534.1390. 
 
(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((1-hydroxy-3-methyl-1,1-diphenylbutan-
2-yl)amino)cyclobut-3-ene-1,2-dione (4b). White solid (ether). 150 mg, 65% yield. m.p. 197-
198 °C. [α]D24 = -647 (c = 0.5, MeOH). IR (neat) = 3215, 2986, 1696, 1497,740 cm-1. 1H NMR 
(500 MHz, DMSO-d6): δ 8.28 (s, 1H), 8.21 (d, J = 11.00 Hz, 1H), 8.04 (d, J = 10.50 Hz, 1H), 7.50-
7.43 (m, 4H), 7.34-7.23 (m, 4H), 7.20-7.11 (m, 1H), 5.76 (s, 1H), 5.68 (s, 1H), 5.12-5.10 (m, 1H), 
4.40 (s, 1H), 4.19 (s, 1H), 0.93 (d, J = 7.00 Hz, 3H), 0.75 (t, J = 6.50 Hz, 3H). 13C NMR (125 MHz, 
DMSO-d6): δ 189.8, 182.4, 177.3, 173.1, 146.8, 130.2, 129.3, 128.8, 128.3, 128.1, 127.9, 127.5, 
126.6, 126.0, 125.8, 125.6, 125.5, 125.0, 80.5, 63.7, 28.5, 22.4, 17.7. EI-MS m/z: 562 (M)+. HRMS 
(EI) calcd for C29H24F6N2O3 m/z: 562.1691 (M)
+ found: 562.1705. 
 
 
(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((1-hydroxy-1,1,3-triphenylpropan-2-
yl)amino)cyclobut-3-ene-1,2-dione (4d). White solid (MeOH). 100 mg, 59% yield. m.p. 253-
255 °C. [α]D24 = -25 (c = 0.5, MeOH). IR (neat) = 3265, 2986, 1686, 1446, 855 cm-1. 1H NMR 
(500 MHz, DMSO-d6): δ 10.15 (s, 1H), 8.05 (d, J = 10.00 Hz, 1H), 7.93 (s, 2H), 7.66 (d, J = 7.50 
Hz, 2H), 7.60 (s, 1H), 7.54 (d, J = 7.50 Hz, 2H), 7.46 (t, J = 7.50 Hz, 2H), 7.29 (t, J = 7.50 Hz, 
1H), 7.19 (t, J = 7.50 Hz, 4H), 7.15-7.05 (m, 4H), 6.62 (s, 1H), 5.47-5.41 (m, 1H), 2.83 (d, J = 
7.00 Hz, 2H). 13C NMR (125 MHz, DMSO-d6): δ 183.8, 179.6, 169.6, 160.9, 145.4, 145.1, 141.0, 
137.9, 131.5, 131.2, 129.3, 128.6, 128.2, 127.9, 127.0, 126.4, 125.5, 124.2, 122.0, 117.6, 79.7, 
62.2, 36.8. EI-MS m/z: 610 (M)+, 633 (M + Na)+. HRMS (EI) calcd for C33H24F6N2O3 m/z: 
610.1691 (M)+ found: 610.1697. 
General procedure for Synthesis of compounds 13a-e. Compound 11 (1 mmol) compound was 
charged in 50 mL round bottomed flask and the corresponding cyclic amine (5 mmol) was added 
drop-wise at room temperature. After 5 min stirring the temperature was raised to 70° C and 
allowed to stirred for 12 h. After completion of the reaction, crude reaction mixture was purified 
by flash column chromatography using Hexane:EtOAc (7:3) as eluent to give the compounds 12a-
e (55% - 65%), Next, the compounds 12 (1 mmol) compounds were dissolved in DCM (10 mL) 
followed by slow addition of TFA (0.382 mL, 10 mmol) at 0 oC and stirred for 1 h at room 
temperature. After completion of reaction the residue was basified using with saturated aq. 
NaHCO3 solution and extracted in DCM (3x15 mL) and the combined organic layers were washed 
with brine and dried over Na2SO4.  The solvent was evaporated under reduced pressure to yield the 
resulted -tertiary amine aminoalcohols 13a-e (85% - 95%) as pure compounds without further 
purification. 
 (S)-2-Amino-1,1-diphenyl-3-(pyrrolidin-1-yl)propan-1-ol (13a).  Light yellow solid (Ether). 
135 mg, 90% yield. m.p. 113-115 °C. [α]D24 = -74 (c = 1.09, EtOH ). IR (neat) = 2933, 2803, 1556, 
1448, 1355 cm-1. 1H NMR (500 MHz, CDCl3): δ 7.64 (d, J = 8.50 Hz, 2H), 7.53 (d, J = 8.50 Hz, 
2H), 7.33-7.25 (m, 4H), 7.20-7.13 (m, 2H), 3.92 (q, J1 = 3.50, 7.00 Hz, 1H), 2.76 (q, J1 = 7.00, 
13.00 Hz, 1H), 2.62-2.60 (m, 2H), 2.42-2.40 (m, 2H), 2.28 (dd, J1 = 3.50, 13.00 Hz, 1H), 1.76-
1.70 (m, 4H). 13C NMR (125 MHz, CDCl3): δ 146.3, 145.8, 128.4, 128.2. 126.6, 126.5, 125.9, 
125.6, 79.9, 57.6, 55.1, 55.0, 23.7; FAB-MS m/z: 297 (M+H)+. HRMS (FAB) calcd for C19H25N2O 
m/z: 297.1967 (M+H)+ found: 297.1963. 
 
(S)-2-Amino-1,1-diphenyl-3-(piperidin-1-yl)propan-1-ol (13b). Pale yellow solid (Ether). 145 
mg, 95% yield. m.p. 125-126 °C. [α]D25 = -66 (c = 1.38, EtOH). IR (neat) = 3432, 2836, 2321, 
1561, 1446 cm-1. 1H NMR (500 MHz, CDCl3): δ 7.60 (d, J = 7.50 Hz, 2H), 7.51 (d, J = 7.50 Hz, 
2H), 7.33-7.24 (m, 4H), 7.20-7.15 (m, 2H), 3.96 (q, J1 = 4.50, 6.50 Hz, 1H), 2.62-2.39 (m, 3H), 
2.20-2.16 (m, 3H), 1.57-1.50 (m, 4H), 1.38 (s, 2H). 13C NMR (125 MHz, CDCl3): δ 146.9, 145.2, 
128.3, 128.2, 126.6, 126.5, 126.1, 125.8, 79.5, 59.1, 56.3, 54.0, 28.5, 26.3. FAB-MS m/z: 310 
(M+H)+. HRMS (FAB) calcd for C20H27N2O m/z: 311.2123 (M+H)
+: found: 311.2126.  
  
(S)-2-Amino-3-(azepan-1-yl)-1,1-diphenylpropan-1-ol (13c). Pale yellow solid (Ether). 131 mg, 
86% yield. m.p. 145-146 °C. [α]D23 = -40 (c = 2.4, EtOH). IR (neat) = 3504, 2933, 2326, 1615, 
1452 cm-1. 1H NMR (500 MHz, CDCl3): δ 7.60 (d, J = 8.50 Hz, 2H), 7.51 (d, J = 8.50 Hz, 2H), 
7.33-7.24 (m, 4H), 7.21-7.155 (m, 2H), 3.92 (q, J1= 4.50, 7.50 Hz, 1H), 3.71 (s, 3H), 2.69-2.65 (m, 
2H), 2.57-2.52 (m, 3H), 2.48 (dd, J1 = 4.50, 13.50 Hz, 1H), 1.63-1.56 (m, 5H). 
13C NMR (125 
MHz, CDCl3): δ 146.3, 145.5, 128.4, 128.3, 127.3, 126.6, 126.1, 125.7, 79.8, 59.9, 56.8, 54.5, 28.0, 
27.1. FAB-MS m/z: 325 (M+H)+. HRMS (FAB) calcd for C21H29N2O m/z: 325.2280 (M+H)
+: 
found: 325.2279. 
 
(S)-2-Amino-3-morpholino-1,1-diphenylpropan-1-ol (13d). Light yellow solid (Ether). 130 mg, 
85% yield. m.p. 110-113 °C. [α]D23 = -66 (c = 1.0, EtOH). IR (neat) = 3386, 3324, 2950, 1599, 
1449, 1259 cm-1. 1H NMR (500 MHz, CD3OD): δ 7.29 (d, J = 8.00 Hz, 2H), 7.18 (d, J = 8.00 Hz, 
2H), 6.98 (t, J = 8.00 Hz, 2H), 3.76 (dd, J1 = 3.00, 9.00 Hz, 1H), 2.20 (s, 2H), 2.10 (q, J = 9.00, 
13.00 Hz, 1H), 1.88 (s, 2H), 1.83 (dd, J = 3.00, 12.50 Hz, 1H).  13C NMR (125 MHz, CD3OD) δ: 
147.6, 146.8, 129.5, 129.3, 127.9, 127.8, 127.2, 126.8, 80.7, 68.2, 61.2, 55.4, 54.6. FAB-MS m/z: 
313 (M+H)+. HRMS (FAB) calcd for C19H25N2O2 m/z: 313.1916  (M+H)
+: found: 313.1904.  
 
(S)-2-Amino-1,1-diphenyl-3-thiomorpholinopropan-1-ol (13e). White solid (Ether). 131 mg, 
85% yield. m.p. 94-96 °C. [α]D25 = -74 (c = 1.09, EtOH). IR(neat) = 3582, 2952, 2359, 1673, 1491 
cm-1. 1H NMR (500 MHz, CD3OD): δ 7.73 (s, 1H), 7.48 (d, J = 7.50 Hz, 2H), 7.39 (d, J = 7.50 Hz, 
2H), 7.20-7.12 (m, 2H), 3.93 (s, 1H), 2.64 (s, 2H), 2.48 (s, 2H), 2.35 (s, 2H), 2.30-2.25 (m, 3H), 
2.12 (d, J = 13.00 Hz, 1H). 13C NMR (125 MHz, CD3OD): δ 147.4, 146.8, 129.5, 129.3, 127.9, 
127.8, 127.2, 126.2, 126.9, 80.7, 61.5, 57.2, 54.9, 28.9. EI-MS m/z: 328 (M)+. HRMS (EI) calcd 
for C19H24N2OS m/z: 328.1609 (M)
+: found: 328.1608. 
 
General procedure for synthesis of compounds 14a-e. The squaramide mono-ester amide 3 (100 
mg, 1 mmol) and -tertiaryamine aminoalcohol 13 (1 mmol) were charged in sealed tube in 20 mL 
MeOH solvent and the sealed tube was closed tightly without any air gap and the reaction mixture 
was stirred for 12 h at 120° C. After completion of the reaction indicated by TLC, the excess 
solvent was evaporated under reduced pressure resulted the crude mass, which was purified 
directly by flash column chromatography using CHCl3:MeOH (9:1) as eluent to give the 
compound 14a-e (56% - 81%).  
 
(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((1-hydroxy-1,1-diphenyl-3-(pyrrolidin-1-
yl)propan-2-yl)amino)cyclobut-3-ene-1,2-dione (14a). Brown solid (Ether). 99 mg, 56% yield. 
m.p. 145-146 °C. [α]D25 = -45 (c = 1.0, CHCl3). IR (neat): 3566, 3250, 3198, 2965, 1680, 1596 cm-
1. 1H NMR (500 MHz, CD3OD): δ 8.02 (s, 2H), 7.63 (d, J = 8.50 Hz, 2H), 7.55 (t, J = 7.50 Hz, 
3H), 7.39 (t, J = 8.00 Hz, 2H), 7.26 (t, J = 7. 50 Hz, 1H), 7.21 (t, J = 7.50 Hz, 2H), 7.11 (t, J = 
7.50 Hz, 1H), 5.45 (d, J = 6.50 Hz, 1H), 3.00 (d, J = 8.50 Hz, 1H), 2.77 (s, 2H), 2.60 (d, J = 13.00 
Hz, 1H), 2.46 (s, 2H), 1.78 (s, 4H). 13C NMR (125 MHz, CD3OD): δ 186.1, 182.0, 171.6, 164.0, 
146.5, 146.3, 142.6, 129.7, 129.2, 128.4, 128.1, 127.0, 126.8, 127.0, 126.8, 125.8, 123.7, 119.2, 
116.4, 58.9, 56.0, 24.5. EI-MS m/z: 603 (M)+. HRMS (EI) calcd for C31H27F6N3O3 m/z: 603.1957 
(M)+: found: 603.1948. 
 
(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((1-hydroxy-1,1-diphenyl-3-(piperidin-1-
yl)propan-2-yl)amino)cyclobut-3-ene-1,2-dione (14b). Brown solid (Ether). 100 mg, 54% yield. 
m.p. 125-126° C.  
[α]D25 = -23.00 (c = 1.0, EtOH). IR (neat): 3554, 3447, 1794, 1733, 1671, 1558 cm-1. 1H NMR 
(500 MHz, CD3OD): δ 8.02, (s, 2H), 7.64 (d, J = 7.00 Hz, 2H), 7.56 (d, J = 9.00 Hz, 2H), 7.50 (s, 
1H), 7.40 (t, J = 8.00 Hz, 2H), 7.27 (t, J = 7.50 Hz, 2H), 7.11 (t, J = 7.50 Hz, 1H), 5.53 (d, J = 7.50 
Hz, 1H), 3.17-2.80 (m, 3H), 2.58 (s, 2H), 1.73-1.44 (m, 4H), 1.31-1.25 (m, 2H), 0.88 (t, J = 11.00 
Hz, 1H). 13C NMR (125 MHz, CD3OD): δ 186.1, 182.0, 171.6, 164.2, 145.8, 142.4, 129.9, 129.3, 
128.6, 128.3, 127.1, 126.8, 125.8, 123.6, 119.2, 116.7, 81.4, 60.9, 59.4, 56.1, 32.9, 26.0, 23.9, 14.6. 
FAB-MS m/z: 618 (M+H)+. HRMS (FAB) calcd for C32H30F6N3O3 m/z: 618.2191 (M+H)
+: found: 
618.2203. 
 
(S)-3-((3-(Azepan-1-yl)-1-hydroxy-1,1-diphenylpropan-2-yl)amino)-4-((3,5-
bis(trifluoromethyl)phenyl)amino)cyclobut-3-ene-1,2-dione (14c). Yellow solid (Ether). 117 
mg, 62% yield. m.p. 161-162° C. [α]D23 = -23.00 (c = 1.0, EtOH). IR (neat): 3522, 3493, 1793, 
1648 cm-1. 1H NMR (500 MHz, CDCl3): δ 7.93 (s, 1H), 7.64-7.52 (m, 4H), 7.46 (d, J = 6.00 Hz, 
2H), 7.36 (t, J = 7.50 Hz, 3H), 7.23 (t, J = 6.00 Hz, 2H), 7.17-7.14 (m, 2H), 7.05 (t, J = 7.00 Hz, 
1H), 5.44 (s, 1H), 3.12 (d, J = 14.00 Hz, 1H), 2.94 (s, 1H), 2.60 (s, 2H), 2.41 (s, 2H), 1.61-1.35 
(m, 8H). 13C NMR (125 MHz, CDCl3): δ 182.4, 181.7, 171.6, 162.4, 143.6, 143.0, 139.7, 129.2, 
128.8, 127.7, 127.6, 125.2, 124.9, 124.0, 121.9, 117.7, 116.5, 115.3, 80.3, 59.7, 59.3, 57.8, 54.0, 
27.1, 26.8, 23.6, 22.5. FAB-MS m/z: 632 (M+H)+. HRMS (FAB) calcd for C33H32F6N3O3 m/z: 
632.2342 (M+H)+: found: 632.2341. 
 
(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((1-hydroxy-3-morpholino-1,1-
diphenylpropan-2-yl)amino)cyclobut-3-ene-1,2-dione (14d). White solid (Ether). 142 mg, 78% 
yield. m.p. 238-240 °C. [α]D25 = -8.00 (c = 1.10, EtOH). IR (neat): 3589, 3423, 1797, 1568, 1541 
cm-1. 1H NMR (500 MHz, CD3OD): δ 8.03 (s, 2H), 7.58 (t, J = 7.50 Hz, 4H), 7.53 (s, 1H), 7.37 (t, 
J = 7.50 Hz, 2H), 7.26-7.21 (m, 3H), 7.11 (t, J = 7.00 Hz, 2H), 5.48 (t, J = 4.50 Hz, 1H), 3.63-3.54 
(m, 4H), 2.70 (q, J1 = 9.50 Hz,  13.50 Hz, 3H), 2.54 (d, J = 12.00 Hz, 1H), 2.24 (s, 2H).  
13C NMR 
(125 MHz, CD3OD): δ 186.3, 181.8, 171.8, 163.4, 146.6, 146.4, 142.6, 129.7, 129.3, 128.4, 128.0, 
126.7, 125.8, 123.7, 119.2, 116.6, 80.8, 68.2, 61.4, 60.0, 55.5. FAB-MS m/z: 620 (M+H)+. HRMS 
(FAB) calcd for C31H28F6N3O4 m/z: 620.1984 (M+H)
+: found: 620.1984. 
 
(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((1-hydroxy-1,1-diphenyl-3-
thiomorpholinopropan-2-yl)amino)cyclobut-3-ene-1,2-dione (14e). White solid (Ether). 151 
mg, 81% yield. m.p. 234-236 °C. [α]D25 = -11.00 (c = 1.0, EtOH). IR (neat): 3522, 3462, 1800, 
1652, 1573 cm-1. 1H NMR (500 MHz, CD3OD): δ 8.03 (s, 2H), 7.58 (t, J = 7.50 Hz, 4H), 7.53 (s, 
1H), 7.37 (t, J = 7.50 Hz, 2H), 7.26-7.21 (m, 3H), 7.11 (t, J = 7.00 Hz, 1H), 5.46 (m, 1H), 2.91 (t, 
J = 7.50 Hz, 2H), 2.69-2.49 (m, 8H). 13C NMR (125 MHz, CD3OD) δ: 186.2, 181.8, 171.8, 163.4, 
146.7, 146.4, 142.5, 129.7, 126.3, 128.4, 128.0, 126.9, 126.6, 125.8, 123.6, 119.1, 116.6, 80.8, 
61.6, 60.3, 57.2, 29.0. FAB-MS m/z: 636 (M+H)+. HRMS (FAB) calcd for C31H28F6N3O3S m/z: 
636.1756 (M+H)+: found: 636.1760. 
 
General Procedure for the nitro-aldol reaction. To the stirred solution of isatin 5 (20 mg, 1.0 
equiv.)  and catalyst 14c (0.1 equiv.) in THF (2 mL) was added nitromethane 6 (5.0 equiv.) at 0 
oC and stirring was continued for appropriate times at same temperature. After completion of 
reaction indicated by TLC, the excess solvent was removed under reduced pressure yields the 
crude mass, which was purified by flash column chromatography using Hexane:EtOAC (6:4) 
solvent system to give the nitro aldol product as pure compounds. The chemical yields of 
compound 5 were calculated after isolation by column chromatography. The enantiomeric excess 
and diastereoselctivity values were determined by chiral HPLC using ChiralPak AD-H and AS-H 
columns. 
 
(S)-tert-Butyl 3-hydroxy-3-(nitromethyl)-2-oxoindoline-1-carboxylate (7e). Yellow solid. 24 
mg, 98% yield. m.p. 134 -136 °C. [α]D23 = +2.88 (c = 1.0, EtOH). The ee was determined by HPLC 
[DAICEL chiralpak AD-H column, hexane/2-propanol = 85/15, flow rate: 1.0 mL/min, tr(major) 
= 10.27 min, tr(minor) = 17.46 min, ee = 95 %]. IR (neat): 3995, 1732, 1616, 1540, 1191, 720 cm-
1. (1H NMR, 500 MHz, CDCl3): δ 10.19 (s, 1H), 7.77 (t, J = 8.00 Hz, 1H), 7.66 (t, J = 8.00 Hz, 
1H), 7.44 (t, J = 9.00 Hz, 1H), 7.25-7.19 (m, 1H), 7.08 (s, 1H), 5.22 (q, J1 = 14.00, 19.00 Hz, 2H), 
1.58 (s, 9H). 13C NMR (125 MHz, CDCl3 δ 173.5, 148.9, 140.3, 131.2, 127.1, 125.3, 125.0, 
115.3, 84.7, 78.5, 72.6, 28.4. EI-MS m/z: 308 (M)+. HRMS (EI) calcd for C9H8N2O4 m/z: 208.0484 
(M-Boc)+: found: m/z: 208.0491 (M-Boc)+. 
 
(S)-3-Hydroxy-5-iodo-3-(nitromethyl)indolin-2-one (7k). Brown solid. 24 mg, 97% yield. m.p. 
160-161 °C. [α]D21 = +53.33 (c = 0.3, EtOH). The ee was determined by HPLC DAICEL chiralpak 
AD-H column, hexane/2-propanol = 85/15, flow rate: 1.0 mL/min, tr(minor) = 12.51 min, 
tr(major) = 16.89 min, ee = 62 %]. IR (neat): 3991, 1730, 1615, 1543, 1182, 825 cm-1. 1H NMR 
(500 MHz, DMSO-d6): δ 10.23 (s, 1H), 7.71 (d, J = 1.50 Hz, 1H), 7.57 (dd, J1 = 1.50, 8.00 Hz, 
1H), 6.79 (s, 1H), 6.66 (d, J = 8.0 Hz, 1H), 5.02 (q, J1 = 8.00, 39.50 Hz, 2H). 
13C NMR (125 MHz, 
DMSO-d6): δ 175.3, 142.4, 138.6, 133.1, 130.7, 112.5, 84.6, 77.8, 72.4; EI-MS m/z: 333.9 (M)+. 
HRMS (EI) calcd for C9H7N2O4I m/z: 333.9450 (M)
+: found: 333.9460.  
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